National Taiwan University Hospital

Taipei, Zhongzheng District 100225

2 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Crohn's Disease, HER2-positive Advanced Solid Tumor, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Psoriasis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• THIO Sequenced With Cemiplimab in Advanced NSCLC — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis — Completed